BMJ  2006;332:401-406 (18 February), doi:10.1136/bmj.38756.482882.DE (published 13 February 2006)

Practice

Pregnancy and congenital heart disease

Anselm Uebing, fellow in adult congenital heart disease1, Philip J Steer, professor of obstetrics and gynaecology2, Steve M Yentis, consultant anaesthetist3, Michael A Gatzoulis, professor of cardiology, congenital heart disease1

1 Adult Congenital Heart Disease Unit, Royal Brompton and Harefield NHS Trust and National Heart and Lung Institute at Imperial College, London SW3 6NP, 2 Academic Department of Obstetrics and Gynaecology at Chelsea and Westminster Hospital, Division of Surgery, Oncology, Reproductive Medicine and Anaesthetics, Faculty of Medicine, Imperial College, London, 3 Magill Department of Anaesthesia, Intensive Care and Pain Management, Chelsea and Westminster Hospital, London

Correspondence to: M A Gatzoulis m.gatzoulis@rbh.nthames.nhs.uk

The first 150 words of the full text of this article appear below.

Congenital heart disease occurs in 0.8% of newborn infants around the world. Advances in medical and surgical treatments over the past decades has led to more than 85% of these infants surviving to adulthood.1 2 Most interventions, however, have not been curative and about half of adults with congenital heart disease face the prospect of further surgery, arrhythmia, heart failure, and—if managed inappropriately—premature death. The burden of pregnancy represents a new challenge in women with congenital heart disease.

In the United Kingdom about 250 000 adults have congenital heart disease (also known as "grown up congenital heart disease (GUCH)" patients), and this number is growing.3 Half of these patients are women, most of reproductive age. After suicide, cardiac disease is now the leading cause of maternal death in the UK, with most of these casualties having had congenital heart disease.4 The medical profession should therefore be aware of the risks that . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study
Jon Hyett, Marc Perdu, Gurleen Sharland, Rosalinde Snijders, and Kypros H Nicolaides
BMJ 1999 318: 81-85. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Bedard, E., Dimopoulos, K., Gatzoulis, M. A. (2009). Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?. Eur Heart J 30: 256-265 [Abstract] [Full text]  
  • Presbitero, P., Boccuzzi, G. G., Groot, C. J.M., Roos-Hesselink, J. W. (2009). CHAPTER 33 Pregnancy and Heart Disease. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full text]  
  • Bedard, E., Shore, D. F., Gatzoulis, M. A. (2008). Adult congenital heart disease: a 2008 overview. Br Med Bull 85: 151-180 [Abstract] [Full text]  
  • Diller, G.-P., Gatzoulis, M. A. (2007). Pulmonary Vascular Disease in Adults With Congenital Heart Disease. Circulation 115: 1039-1050 [Abstract] [Full text]  
  • Webb, G., Gatzoulis, M. A. (2006). Atrial Septal Defects in the Adult: Recent Progress and Overview. Circulation 114: 1645-1653 [Full text]  

Rapid Responses:

Read all Rapid Responses

Pregnancy and Congenital Heart Disease
Gillian E Robinson
bmj.com, 18 Feb 2006 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ